Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,000 | -45,900 | 57,500 | 79,300 | 39,800 |
| Depreciation Amortization | 42,900 | 36,900 | 33,500 | 59,500 | 65,200 |
| Income taxes - deferred | 13,200 | -17,000 | -6,800 | -6,200 | -26,300 |
| Accounts receivable | 45,800 | -800 | 67,400 | -15,300 | 8,400 |
| Accounts payable and accrued liabilities | -18,900 | -83,600 | -64,000 | 18,800 | 6,500 |
| Other Working Capital | -65,400 | -59,600 | -143,400 | -4,300 | 91,600 |
| Other Operating Activity | 8,900 | 95,500 | -89,800 | 12,400 | 3,600 |
| Operating Cash Flow | $-2,500 | $-74,500 | $-145,600 | $144,200 | $188,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,200 | -50,600 | -49,100 | -43,100 | -25,900 |
| Net Acquisitions | N/A | -57,500 | 688,600 | N/A | -175,000 |
| Purchase Of Investment | -4,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-24,200 | $-108,100 | $639,500 | $-43,100 | $-200,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 185,000 | N/A | N/A | N/A | 72,000 |
| Debt Repayment | -254,800 | -200 | -339,000 | 0 | -72,000 |
| Common Stock Issued | 3,400 | 5,300 | 17,100 | 4,700 | 400 |
| Common Stock Repurchased | -900 | -3,600 | -900 | -2,500 | -900 |
| Other Financing Activity | -2,700 | 0 | -1,600 | 0 | -900 |
| Financing Cash Flow | $-70,000 | $1,500 | $-324,400 | $2,200 | $-1,400 |
| Exchange Rate Effect | 2,900 | 1,900 | -4,700 | 2,700 | -2,300 |
| Beginning Cash Position | 205,300 | 384,500 | 219,700 | 113,700 | 129,500 |
| End Cash Position | 111,500 | 205,300 | 384,500 | 219,700 | 113,700 |
| Net Cash Flow | $-93,800 | $-179,200 | $164,800 | $106,000 | $-15,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,500 | -74,500 | -145,600 | 144,200 | 188,800 |
| Capital Expenditure | -20,200 | -50,600 | -49,100 | -43,200 | -29,100 |
| Free Cash Flow | -22,700 | -125,100 | -194,700 | 101,000 | 159,700 |